Detergent chemical major, Nirma Group, is leading the race to acquire Glenmark Life Sciences (GLS), according to a report by The Economic Times (ET). Glenmark Pharmaceuticals Ltd owns an 82.8 per cent stake in GLS, which is a leading active pharmaceutical ingredient (API) platform. ET quoted sources as saying that the conglomerate emerged… Continue reading Nirma emerges as frontrunner for Glenmark’s API arm as bid deadline ends